Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beach Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of products for urological and nephrological health. Founded in 1952, the company has established a niche in the market with its line of urinary acidifiers and mineral supplements designed to manage complex urinary conditions and metabolic deficiencies. Their flagship product line, K-Phos, is widely used for urinary acidification and phosphorus supplementation, while Uro-Mag provides high-quality magnesium oxide. The company remains a private, family-oriented business operating out of Tampa, Florida, serving healthcare providers and patients in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beach Pharmaceuticals.